Eiko LifeSciences Limited (BOM:540204)
India · Delayed Price · Currency is INR 53.00
-1.75 (-3.20%)
At close: Jan 19, 2026
Eiko LifeSciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 34.43 | 21.06 | 7.52 | 7.69 | 7.06 | 6.14 | Upgrade |
Depreciation & Amortization | 9.45 | 7.37 | 6.63 | 6.33 | 5.62 | 0.62 | Upgrade |
Loss (Gain) From Sale of Assets | - | -0 | - | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -0.15 | -0.15 | - | -0.32 | - | - | Upgrade |
Other Operating Activities | 5.75 | -2.25 | 1.59 | -2.44 | -1.53 | -2.33 | Upgrade |
Change in Accounts Receivable | -2.83 | 23.48 | -60.28 | -25.43 | -11.48 | -34.15 | Upgrade |
Change in Inventory | 6.05 | -23.89 | -24.78 | 45.5 | -53.94 | -0.64 | Upgrade |
Change in Accounts Payable | -5.09 | 19.34 | 3.35 | -3.03 | -5.47 | 18.95 | Upgrade |
Change in Other Net Operating Assets | 62.73 | -15.72 | -4.82 | 13.94 | -17.54 | 3.16 | Upgrade |
Operating Cash Flow | 109.34 | 29.24 | -70.8 | 42.24 | -77.27 | -8.25 | Upgrade |
Capital Expenditures | -102.91 | -102.91 | -3.47 | -2.25 | -1.55 | - | Upgrade |
Investment in Securities | -0.81 | -31.22 | -39.64 | 2.1 | -0.03 | 4.03 | Upgrade |
Other Investing Activities | -8.69 | 19.69 | 37.62 | 8.89 | 6.42 | 3.58 | Upgrade |
Investing Cash Flow | -114.26 | -114.45 | -5.49 | 8.75 | 5.92 | -29.36 | Upgrade |
Long-Term Debt Issued | - | 27.63 | - | - | 27.95 | 15.63 | Upgrade |
Total Debt Issued | 23.37 | 27.63 | - | - | 27.95 | 15.63 | Upgrade |
Long-Term Debt Repaid | - | - | - | -45.53 | - | - | Upgrade |
Total Debt Repaid | -9.99 | - | - | -45.53 | - | - | Upgrade |
Net Debt Issued (Repaid) | 13.38 | 27.63 | - | -45.53 | 27.95 | 15.63 | Upgrade |
Issuance of Common Stock | 43.46 | 43.46 | 205.05 | - | 9.5 | 63.4 | Upgrade |
Other Financing Activities | -2.37 | -1.54 | -1.42 | -1.5 | -4.64 | -0.88 | Upgrade |
Financing Cash Flow | 54.47 | 69.56 | 203.62 | -47.04 | 32.8 | 78.15 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | -0 | -0 | 0 | - | - | Upgrade |
Net Cash Flow | 49.55 | -15.65 | 127.34 | 3.95 | -38.55 | 40.54 | Upgrade |
Free Cash Flow | 6.43 | -73.67 | -74.26 | 39.99 | -78.82 | -8.25 | Upgrade |
Free Cash Flow Margin | 1.56% | -19.56% | -26.59% | 21.83% | -31.02% | -6.88% | Upgrade |
Free Cash Flow Per Share | 0.48 | -5.65 | -7.20 | 4.09 | -10.09 | -2.16 | Upgrade |
Cash Interest Paid | 2.42 | 1.59 | 1.42 | 1.5 | 4.64 | 0.88 | Upgrade |
Cash Income Tax Paid | 4.91 | 3.09 | 0.34 | -0.75 | 2.11 | 1.82 | Upgrade |
Levered Free Cash Flow | 5.26 | -78.93 | -77.13 | 47.74 | -92.58 | -63.62 | Upgrade |
Unlevered Free Cash Flow | 6.74 | -77.97 | -76.25 | 48.67 | -90.27 | -63.07 | Upgrade |
Change in Working Capital | 60.85 | 3.21 | -86.53 | 30.98 | -88.43 | -12.68 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.